Protection against malaria after immunization by chloroquine prophylaxis and sporozoites is mediated by preerythrocytic immunity

Proceedings of the National Academy of Sciences of the United States of America

Volumn 110, Issue 19, 2013, Pages 7862-7867

  Bijker, Else M ^a   Bastiaens, Guido J H ^a   Teirlinck, Anne C ^a   Van Gemert, Geert Jan ^a   Graumans, Wouter ^a   Van De Vegte Bolmer, Marga ^a   Siebelink Stoter, Rianne ^a   Arens, Theo ^a   Teelen, Karina ^a   Nahrendorf, Wiebke ^b   Remarque, Edmond J ^c   Roeffen, Will ^a   Jansens, Annemieke ^a   Zimmerman, Dunja ^a   Vos, Martijn ^a   Van Schaijk, Ben C L ^a   Wiersma, Jorien ^a   Van Der Ven, André J A M ^a   De Mast, Quirijn ^a   Van Lieshout, Lisette ^d   Verweij, Jaco J ^d,e   Hermsen, Cornelus C ^a   Scholzen, Anja ^a   Sauerwein, Robert W ^a   more..

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

^c BIOMEDICAL PRIMATE RESEARCH CENTRE   (Netherlands)

^d LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^e CPRLab   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CHLOROQUINE; D DIMER; GAMMA INTERFERON; IMMUNOGLOBULIN G; MONOKINE;

ADULT; ANTIBODY TITER; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ERYTHROCYTE; FEMALE; FEVER; HEADACHE; HUMAN; HUMAN CELL; IMMUNITY; IMMUNIZATION; IN VITRO STUDY; LYMPHOCYTE PROLIFERATION; MALAISE; MALARIA FALCIPARUM; MALE; NAUSEA; PLASMODIUM (LIFE CYCLE STAGE); PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; SPOROZOITE; T LYMPHOCYTE;

ADOLESCENT; ADULT; ANIMALS; ANOPHELES; ANTIGENS, PROTOZOAN; ANTIMALARIALS; CHLOROQUINE; ERYTHROCYTES; HUMANS; KINETICS; MALARIA VACCINES; MALARIA, FALCIPARUM; PLASMODIUM FALCIPARUM; SPOROZOITES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84877347551     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1220360110     Document Type: Article

References (37)

1. World Health Organization (2011) World Malaria Report 2011 (World Health Organization, Geneva).
2. Sauerwein RW (2009) Clinical malaria vaccine development. Immunol Lett 122(2): 115-117.
3. Roestenberg M, et al. (2009) Protection against a malaria challenge by sporozoite inoculation. N Engl J Med 361(5): 468-477.
4. Roestenberg M, et al. (2011) Long-term protection against malaria after experimental sporozoite inoculation: An open-label follow-up study. Lancet 377(9779): 1770-1776.
5. Hoffman SL, et al. (2002) Protection of humans against malaria by immunization with radiation-attenuated Plasmodium falciparum sporozoites. J Infect Dis 185(8): 1155-1164.
6. Yayon A, Vande Waa JA, Yayon M, Geary TG, Jensen JB (1983) Stage-dependent effects of chloroquine on Plasmodium falciparum in vitro. J Protozool 30(4): 642-647.
7. Teirlinck AC, et al. (2011) Longevity and composition of cellular immune responses following experimental Plasmodium falciparum malaria infection in humans. PLoS Pathog 7(12):e1002389, 10.1001371/journal.ppat.1002389.
8. Tarun AS, et al. (2008) A combined transcriptome and proteome survey of malaria parasite liver stages. Proc Natl Acad Sci USA 105(1): 305-310.
9. Butler NS, Vaughan AM, Harty JT, Kappe SH (2012) Whole parasite vaccination approaches for prevention of malaria infection. Trends Immunol 33(5): 247-254.
10. Pombo DJ, et al. (2002) Immunity to malaria after administration of ultra-low doses of red cells infected with Plasmodium falciparum. Lancet 360(9333): 610-617.
11. Rombo L, Bergqvist Y, Hellgren U (1987) Chloroquine and desethylchloroquine concentrations during regular long-term malaria prophylaxis. Bull World Health Organ 65(6): 879-883.
12. Frisk-Holmberg M, Bergqvist Y, Termond E, Domeij-Nyberg B (1984) The single dose kinetics of chloroquine and its major metabolite desethylchloroquine in healthy subjects. Eur J Clin Pharmacol 26(4): 521-530.
13. Sauerwein RW, Roestenberg M, Moorthy VS (2011) Experimental human challenge infections can accelerate clinical malaria vaccine development. Nat Rev Immunol 11(1): 57-64.
14. McCall MB, Sauerwein RW (2010) Interferon-γ - central mediator of protective immune responses against the pre-erythrocytic and blood stage of malaria. J Leukoc Biol 88(6): 1131-1143.
15. Farber JM (1990) A macrophage mRNA selectively induced by gamma-interferon encodes a member of the platelet factor 4 family of cytokines. Proc Natl Acad Sci USA 87(14): 5238-5242.
16. Shortt HE, Fairley NH, Covell G, Shute PG, Garnham PC (1951) The pre-erythrocytic stage of Plasmodium falciparum. Trans R Soc Trop Med Hyg 44(4): 405-419.
17. Roestenberg M, de Vlas SJ, Nieman A-E, Sauerwein RW, Hermsen CC (2012) Efficacy of preerythrocytic and blood-stage malaria vaccines can be assessed in small sporozoite challenge trials in human volunteers. J Infect Dis 206(3): 319-323.
18. Doolan DL, Dobaño C, Baird JK (2009) Acquired immunity to malaria. Clin Microbiol Rev 22(1): 13-36.
19. Clyde DF (1990) Immunity to falciparum and vivax malaria induced by irradiated sporozoites: A review of the University of Maryland studies, 1971-75. Bull World Health Organ 68(Suppl): 9-12.
20. Collins WE, Jeffery GM (1999) A retrospective examination of secondary sporozoiteand trophozoite-induced infections with Plasmodium falciparum: Development of parasitologic and clinical immunity following secondary infection. Am J Trop Med Hyg 61(1, Suppl):(Suppl): 20-35.
21. Edstein MD, et al. (2005) Lengthy antimalarial activity of atovaquone in human plasma following atovaquone-proguanil administration. Antimicrob Agents Chemother 49(10): 4421-4422.
22. Baird JK, et al. (2003) Onset of clinical immunity to Plasmodium falciparum among Javanese migrants to Indonesian Papua. Ann Trop Med Parasitol 97(6): 557-564.
23. Artavanis-Tsakonas K, et al. (2003) Activation of a subset of human NK cells upon contact with Plasmodium falciparum-infected erythrocytes. J Immunol 171(10): 5396-5405.
24. Hermsen CC, et al. (2003) Circulating concentrations of soluble granzyme A and B increase during natural and experimental Plasmodium falciparum infections. Clin Exp Immunol 132(3): 467-472.
25. McCall MB, et al. (2010) Memory-like IFN-γ response by NK cells following malaria infection reveals the crucial role of T cells in NK cell activation by P. falciparum. Eur J Immunol 40(12): 3472-3477.
26. Schofield L, Grau GE (2005) Immunological processes in malaria pathogenesis. Nat Rev Immunol 5(9): 722-735.
27. Cohen S, McGregor IA, Carrington S (1961) Gamma-globulin and acquired immunity to human malaria. Nature 192: 733-737.
28. Belnoue E, et al. (2004) Protective T cell immunity against malaria liver stage after vaccination with live sporozoites under chloroquine treatment. J Immunol 172(4): 2487-2495.
29. Schofield L, et al. (1987) Gamma interferon, CD8+ T cells and antibodies required for immunity to malaria sporozoites. Nature 330(6149): 664-666.
30. Weiss WR, Sedegah M, Beaudoin RL, Miller LH, Good MF (1988) CD8+ T cells (cytotoxic/ suppressors) are required for protection in mice immunized with malaria sporozoites. Proc Natl Acad Sci USA 85(2): 573-576.
31. Goodman AL, Draper SJ (2010) Blood-stage malaria vaccines - recent progress and future challenges. Ann Trop Med Parasitol 104(3): 189-211.
32. Cheng Q, et al. (1997) Measurement of Plasmodium falciparum growth rates in vivo: A test of malaria vaccines. Am J Trop Med Hyg 57(4): 495-500.
33. Duncan CJ, et al. (2011) Impact on malaria parasite multiplication rates in infected volunteers of the protein-in-adjuvant vaccine AMA1-C1/Alhydrogel+CPG 7909. PLoS One 6(7):e22271.
34. Lawrence G, et al. (2000) Effect of vaccination with 3 recombinant asexual-stage malaria antigens on initial growth rates of Plasmodium falciparum in non-immune volunteers. Vaccine 18(18): 1925-1931.
35. McCarthy JS, et al. (2011) A pilot randomised trial of induced blood-stage Plasmodium falciparum infections in healthy volunteers for testing efficacy of new antimalarial drugs. PLoS One 6(8):e21914.
36. Sanderson F, et al. (2008) Blood-stage challenge for malaria vaccine efficacy trials: A pilot study with discussion of safety and potential value. Am J Trop Med Hyg 78(6): 878-883.
37. Adegnika AA, et al. (2006) Microscopic and sub-microscopic Plasmodium falciparum infection, but not inflammation caused by infection, is associated with low birth weight. Am J Trop Med Hyg 75(5): 798-803.